We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CONMED Corporation | NASDAQ:CNMD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 101.41 | 100.00 | 106.01 | 0 | 01:00:00 |
|
|
|
Page
|
|
|
|
|
Financial Statements:
|
|
|
|
|
|
|
|
|
|
Supplemental Schedule: *
|
|
|
|
|
|
*
|
All other schedules required by 29 CFR 2520.103-10 of the Department of Labor’s Rules and Regulations for Reporting and Disclosure under ERISA have been omitted because they are not applicable.
|
/s/
|
Insero & Co. CPAs, LLP
|
|
|
Certified Public Accountants
|
|
|
|
|
|
We have served as the Plan’s auditor since the year ended December 31, 2003.
|
|
|
|
|
|
Rochester, New York
|
|
|
June 19, 2019
|
|
CONMED Corporation
|
Retirement Savings Plan
|
|
Statements of Net Assets Available for Benefits
|
December 31, 2018 and 2017
|
|
|
2018
|
|
2017
|
||||
Assets
|
|
|
|
|
|
|
||
Investments, at Fair Value
|
|
|
|
|
|
|
||
Mutual Funds
|
|
$
|
167,403,884
|
|
|
$
|
176,075,407
|
|
Common Collective Trust
|
|
9,977,951
|
|
|
9,746,681
|
|
||
Common Stock
|
|
9,362,168
|
|
|
8,164,816
|
|
||
Preferred Stock
|
|
143,307
|
|
|
159,025
|
|
||
Corporate Bonds
|
|
53,131
|
|
|
77,311
|
|
||
Money Market Funds
|
|
8,754,690
|
|
|
9,284,371
|
|
||
|
|
|
|
|
||||
Total Investments, at Fair Value
|
|
195,695,131
|
|
|
203,507,611
|
|
||
|
|
|
|
|
||||
Non-interest bearing cash
|
|
3,026
|
|
|
—
|
|
||
|
|
|
|
|
||||
Receivables
|
|
|
|
|
||||
Participant Contributions Receivable
|
|
39,474
|
|
|
—
|
|
||
Employer Contributions Receivable
|
|
33,890
|
|
|
—
|
|
||
Notes Receivable from Participants
|
|
4,499,639
|
|
|
4,825,686
|
|
||
Other Receivables
|
|
—
|
|
|
54,390
|
|
||
|
|
|
|
|
||||
Total Receivables
|
|
4,573,003
|
|
|
4,880,076
|
|
||
|
|
|
|
|
||||
Total Assets
|
|
200,271,160
|
|
|
208,387,687
|
|
||
|
|
|
|
|
||||
Liabilities
|
|
|
|
|
|
|
||
Other Liabilities
|
|
—
|
|
|
20,207
|
|
||
|
|
|
|
|
||||
Total Liabilities
|
|
—
|
|
|
20,207
|
|
||
|
|
|
|
|
||||
Net Assets Available for Benefits
|
|
$
|
200,271,160
|
|
|
$
|
208,367,480
|
|
CONMED Corporation
|
Retirement Savings Plan
|
|
Statement of Changes in Net Assets Available for Benefits
|
Year Ended December 31, 2018
|
Additions to net assets attributed to:
|
|
|
|
Interest and dividends
|
$
|
12,058,931
|
|
Interest on notes receivable from participants
|
233,844
|
|
|
Contributions:
|
|
|
|
Participants
|
12,502,766
|
|
|
Employer
|
7,883,385
|
|
|
|
|
|
|
Total additions
|
32,678,926
|
|
|
|
|
|
|
Deductions from net assets attributed to:
|
|
|
|
Net depreciation in fair value of investments
|
22,782,549
|
|
|
Administrative expenses
|
145,791
|
|
|
Distributions to participants
|
17,846,906
|
|
|
|
|
|
|
Total deductions
|
40,775,246
|
|
|
|
|
|
|
Net decrease
|
(8,096,320
|
)
|
|
|
|
|
|
Net assets available for benefits at beginning of year
|
208,367,480
|
|
|
|
|
||
Net assets available for benefits at end of year
|
$
|
200,271,160
|
|
•
|
Quoted prices for similar assets or liabilities in active markets;
|
•
|
Quoted prices for identical or similar assets or liabilities in inactive markets;
|
•
|
Inputs other than quoted prices that are observable for the asset or liability;
|
•
|
Inputs that are derived principally from, or corroborated by, observable market data by correlation or other means.
|
|
|
Investments at Fair Value as of
|
||||||
|
|
December 31, 2018
|
||||||
|
|
Level 1
|
|
Total
|
||||
Mutual Funds
|
|
$
|
167,403,884
|
|
|
$
|
167,403,884
|
|
Common Stock
|
|
9,362,168
|
|
|
9,362,168
|
|
||
Preferred Stock
|
|
143,307
|
|
|
143,307
|
|
||
Corporate Bonds
|
|
53,131
|
|
|
53,131
|
|
||
Money Market Funds
|
|
8,754,690
|
|
|
8,754,690
|
|
||
Investments measured at fair value
|
|
185,717,180
|
|
|
185,717,180
|
|
||
Investments measured at NAV as a practical expedient (a)
|
|
|
|
|
9,977,951
|
|
||
Total investments at fair value
|
|
|
|
|
$
|
195,695,131
|
|
|
|
Investments at Fair Value as of
|
||||||
|
|
December 31, 2017
|
||||||
|
|
Level 1
|
|
Total
|
||||
Mutual Funds
|
|
$
|
176,075,407
|
|
|
$
|
176,075,407
|
|
Common Stock
|
|
8,164,816
|
|
|
8,164,816
|
|
||
Preferred Stock
|
|
159,025
|
|
|
159,025
|
|
||
Corporate Bonds
|
|
77,311
|
|
|
77,311
|
|
||
Money Market Funds
|
|
9,284,371
|
|
|
9,284,371
|
|
||
Investments measured at fair value
|
|
193,760,930
|
|
|
193,760,930
|
|
||
Investments measured at NAV as a practical expedient (a)
|
|
|
|
|
9,746,681
|
|
||
Total investments at fair value
|
|
|
|
|
$
|
203,507,611
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||||||||
|
|
Number
of
Shares
|
|
Fair
Value
|
|
Number
of
Shares
|
|
Fair
Value
|
||||||
CONMED Corporation
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Common Stock
|
|
98,309
|
|
|
$
|
6,311,462
|
|
|
100,393
|
|
|
$
|
5,117,031
|
|
CONMED Corporation
|
Retirement Savings Plan
|
|
Schedule H, line 4i - Schedule of Assets (Held at End of Year)
|
December 31, 2018
|
|
|
Current
|
||
Identity of Issue/Description of Investment
|
|
Value
|
||
|
|
|
|
|
Fidelity 500 Index Fund**
|
|
$
|
15,471,202
|
|
Janus Henderson Enterprise Fund Class N
|
|
14,013,559
|
|
|
Fidelity Puritan Fund - Class K**
|
|
13,479,219
|
|
|
Fidelity Managed Income Portfolio Class 1**
|
|
9,977,951
|
|
|
Fidelity Freedom 2025 Fund - Class K**
|
|
9,466,415
|
|
|
Fidelity Freedom 2040 Fund - Class K**
|
|
9,394,518
|
|
|
Fidelity Freedom 2030 Fund - Class K**
|
|
9,269,946
|
|
|
Fidelity Freedom 2045 Fund - Class K**
|
|
8,657,864
|
|
|
Fidelity Low-Priced Stock Fund - Class K**
|
|
8,642,659
|
|
|
Fidelity Investment Grade Bond Fund**
|
|
8,466,646
|
|
|
Fidelity Freedom 2035 Fund - Class K**
|
|
7,741,224
|
|
|
Participant - Directed BrokerageLink Account
|
|
7,453,079
|
|
|
Fidelity Freedom 2020 Fund - Class K**
|
|
7,352,785
|
|
|
MFS Value R6
|
|
7,180,144
|
|
|
Fidelity Capital Appreciation Fund Class K**
|
|
6,749,037
|
|
|
T. Rowe Price Dividend Growth Fund - I Class
|
|
6,622,729
|
|
|
Fidelity Government Money Market Fund**
|
|
6,428,716
|
|
|
Fidelity Diversified International Fund - Class K**
|
|
6,333,565
|
|
|
CONMED Corporation Common Stock **
|
|
6,311,462
|
|
|
Fidelity Freedom 2050 Fund - Class K**
|
|
6,242,457
|
|
|
Vanguard Total Bond Market Index Admiral Fund
|
|
3,638,349
|
|
|
Fidelity Extended Market Index Fund**
|
|
3,085,215
|
|
|
Fidelity Freedom 2055 Fund - Class K**
|
|
2,369,520
|
|
|
JP Morgan U.S. Small Company Fund Class R6
|
|
2,133,181
|
|
|
Fidelity Global ex U.S. Index Fund**
|
|
2,073,394
|
|
|
Fidelity Freedom 2015 Fund - Class K**
|
|
1,531,647
|
|
|
Wells Fargo Emerging Markets Equity Fund R6
|
|
1,480,288
|
|
|
Delaware Small Cap Value R6 Fund
|
|
1,437,002
|
|
|
Fidelity Freedom Income Fund - Class K**
|
|
976,167
|
|
|
Fidelity Contrafund - Class K**
|
|
760,831
|
|
|
Fidelity Freedom 2010 Fund - Class K**
|
|
611,657
|
|
|
Fidelity Freedom 2060 Fund - Class K**
|
|
311,308
|
|
|
Fidelity Freedom 2005 Fund - Class K**
|
|
30,418
|
|
|
Interest Bearing Cash Accounts
|
|
977
|
|
|
|
|
|
||
Notes receivable from participants, interest rates from
|
|
|
|
|
4.25% to 9.25% and maturities from 2019 to 2033**
|
|
4,499,639
|
|
|
|
|
|
|
|
|
|
$
|
200,194,770
|
|
** Denotes party-in-interest
|
|
CONMED CORPORATION
|
|
|
Retirement Savings Plan
|
|
|
|
|
|
By:
|
/s/ Todd W. Garner
|
|
Name:
|
Todd W. Garner
|
|
Title:
|
Executive Vice President & Chief Financial Officer
|
1 Year CONMED Chart |
1 Month CONMED Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions